Search

everythinglearnresearchcommunity

for

Search:↓

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

KLB and EIF3C genes are key for early diagnosis of vitiligo and alopecia areata.

Surgical treatments and topical tofacitinib may help with vitiligo-related eyebrow and eyelash whitening, but more research is needed.

Rhododendrol in skin-whitening products can cause skin depigmentation and immune reactions.

The 2-step surgery effectively treats stable follicular vitiligo with high patient satisfaction and no major complications.

Certain gene variations and different levels of BDNF and CRH hormones are linked to vitiligo.

Vitiligo and alopecia areata may have similar causes despite their differences.

Vitiligo causes significant emotional stress in Africa, the Middle East, and Latin America, with limited treatment options available.

A woman with multiple autoimmune diseases showed improvement in hair loss but not in skin discoloration after treatment.

The new drug delivery system improves vitiligo treatment by enhancing melanocyte activity and viability.

A medication may help with hair growth in psoriasis, and a skin condition might be linked to a specific bacteria.

Combining laser with PRP is more effective for vitiligo than PRP alone.

Chemical leukoderma is temporary, while chemical-induced vitiligo can be persistent and harder to treat.

Elevated granulysin levels may indicate disease activity in vitiligo and alopecia areata.

Upadacitinib and narrowband UVB effectively treated a child's vitiligo and alopecia areata.

Congenital triangular alopecia and vitiligo can occur together, but treatment for one may not affect the other.

The new method combining dermoscopy and Reflectance Confocal Microscopy is more effective for evaluating vitiligo.

Vitiligo is now seen as a systemic disease with promising new treatments and may offer protection against some diseases.

Alopecia areata patients have worse quality of life, anxiety, and depression than vitiligo patients.

Vitiligo is a systemic disease with psychological effects, and new treatments focus on personalized care.

Topical eyedrops may cause eyelash whitening and skin lightening around the eyes.

Vitiligo treatments are improving but relapses are common.

Vitiligo and alopecia should be covered by Medicaid and TRICARE as medical, not cosmetic, conditions.

Treatments for melanin disorders exist, but more effective options needed.

Topical vitamin D is useful for some skin conditions but not effective for others, and more research is needed.

Contact immunotherapy might help treat various skin conditions, but more research is needed to confirm its safety and effectiveness.

Bee venom might be a good alternative treatment for various skin conditions because it has many healing properties.

Reliable, non-invasive tools are needed for better vitiligo diagnosis.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Understanding how melanocyte stem cells work could lead to new treatments for hair graying and skin pigmentation disorders.